286 related articles for article (PubMed ID: 33422652)
1. Targeting T-type/CaV3.2 channels for chronic pain.
Cai S; Gomez K; Moutal A; Khanna R
Transl Res; 2021 Aug; 234():20-30. PubMed ID: 33422652
[TBL] [Abstract][Full Text] [Related]
2. Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis.
Shin SM; Cai Y; Itson-Zoske B; Qiu C; Hao X; Xiang H; Hogan QH; Yu H
Mol Pain; 2020; 16():1744806920963807. PubMed ID: 33054557
[TBL] [Abstract][Full Text] [Related]
3. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of interleukin-6 on Ca
Liu Q; Chen W; Fan X; Wang J; Fu S; Cui S; Liao F; Cai J; Wang X; Huang Y; Su L; Zhong L; Yi M; Liu F; Wan Y
Exp Neurol; 2019 Jul; 317():226-243. PubMed ID: 30872136
[TBL] [Abstract][Full Text] [Related]
5. Cdk5-Dependent Phosphorylation of Ca
Gomez K; Calderón-Rivera A; Sandoval A; González-Ramírez R; Vargas-Parada A; Ojeda-Alonso J; Granados-Soto V; Delgado-Lezama R; Felix R
J Neurosci; 2020 Jan; 40(2):283-296. PubMed ID: 31744861
[TBL] [Abstract][Full Text] [Related]
6. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S
PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104
[TBL] [Abstract][Full Text] [Related]
7. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Ca
Liu QY; Chen W; Cui S; Liao FF; Yi M; Liu FY; Wan Y
Neurosci Res; 2019 May; 142():30-37. PubMed ID: 29684385
[TBL] [Abstract][Full Text] [Related]
9. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A
Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819
[TBL] [Abstract][Full Text] [Related]
10. Effect of ABT-639 on Cav3.2 channel activity and its analgesic actions in mouse models of inflammatory and neuropathic pain.
Antunes FTT; Huang S; Chen L; Zamponi GW
Eur J Pharmacol; 2024 Mar; 967():176416. PubMed ID: 38342359
[TBL] [Abstract][Full Text] [Related]
11. Chronic intrathecal infusion of T-type calcium channel blockers attenuates Ca
Shiue SJ; Wang CH; Wang TY; Chen YC; Cheng JK
Acta Anaesthesiol Taiwan; 2016 Sep; 54(3):81-87. PubMed ID: 27765616
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
Yue J; Liu L; Liu Z; Shu B; Zhang Y
Spine (Phila Pa 1976); 2013 Mar; 38(6):463-70. PubMed ID: 22972512
[TBL] [Abstract][Full Text] [Related]
13. Genetic alteration of the metal/redox modulation of Cav3.2 T-type calcium channel reveals its role in neuronal excitability.
Voisin T; Bourinet E; Lory P
J Physiol; 2016 Jul; 594(13):3561-74. PubMed ID: 26931411
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Ca
Kang XJ; Chi YN; Chen W; Liu FY; Cui S; Liao FF; Cai J; Wan Y
Mol Pain; 2018; 14():1744806918765808. PubMed ID: 29592785
[TBL] [Abstract][Full Text] [Related]
15. H2S and Pain: A Novel Aspect for Processing of Somatic, Visceral and Neuropathic Pain Signals.
Terada Y; Kawabata A
Handb Exp Pharmacol; 2015; 230():217-30. PubMed ID: 26162837
[TBL] [Abstract][Full Text] [Related]
16. Nerve injury elevates functional Cav3.2 channels in superficial spinal dorsal horn.
Feng XJ; Ma LX; Jiao C; Kuang HX; Zeng F; Zhou XY; Cheng XE; Zhu MY; Zhang DY; Jiang CY; Liu T
Mol Pain; 2019; 15():1744806919836569. PubMed ID: 30803310
[TBL] [Abstract][Full Text] [Related]
17. Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway.
Stemkowski PL; Garcia-Caballero A; Gadotti VM; M'Dahoma S; Chen L; Souza IA; Zamponi GW
Mol Pain; 2017; 13():1744806917724698. PubMed ID: 28741432
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain.
Sekiguchi F; Kawara Y; Tsubota M; Kawakami E; Ozaki T; Kawaishi Y; Tomita S; Kanaoka D; Yoshida S; Ohkubo T; Kawabata A
Pain; 2016 Aug; 157(8):1655-1665. PubMed ID: 27023424
[TBL] [Abstract][Full Text] [Related]
19. Ca
Tomita S; Sekiguchi F; Kasanami Y; Naoe K; Tsubota M; Wake H; Nishibori M; Kawabata A
Eur J Pharmacol; 2020 Dec; 888():173587. PubMed ID: 32971090
[TBL] [Abstract][Full Text] [Related]
20. Cav3.2 T-Type Calcium Channel Mediates Acute Itch and Contributes to Chronic Itch and Inflammation in Experimental Atopic Dermatitis.
Ahn JW; Kim SE; Kim DY; Jeong I; Kim S; Chung S; Lee SE
J Invest Dermatol; 2024 Mar; 144(3):612-620.e6. PubMed ID: 37863387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
